![Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses | PNAS Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses | PNAS](https://www.pnas.org/cms/asset/2de643c2-7c12-4647-9f85-d316cb6f075b/keyimage.jpg)
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses | PNAS
![A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice - ScienceDirect A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001620301994-fx1.jpg)
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice - ScienceDirect
![Self-amplifying mRNA bicistronic influenza vaccines raise cross-reactive immune responses in mice and prevent infection in ferrets: Molecular Therapy - Methods & Clinical Development Self-amplifying mRNA bicistronic influenza vaccines raise cross-reactive immune responses in mice and prevent infection in ferrets: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/6062b00f-e6e9-4767-addd-318572cb4644/fx1_lrg.jpg)
Self-amplifying mRNA bicistronic influenza vaccines raise cross-reactive immune responses in mice and prevent infection in ferrets: Molecular Therapy - Methods & Clinical Development
![Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions | Science | AAAS Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions | Science | AAAS](https://www.science.org/do/10.1126/science.abg2359/abs/vaccine_1280p_3.jpg)
Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions | Science | AAAS
![COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee - ScienceDirect COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1939455121000119-gr1.jpg)
COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee - ScienceDirect
![Frontiers | Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response Frontiers | Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response](https://www.frontiersin.org/files/Articles/878943/fimmu-13-878943-HTML-r1/image_m/fimmu-13-878943-g004.jpg)